Hannestad J, Duclos T, Chao W, Koborsi K, et al. Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial. J Alzheimers Dis 2021 May 3. pii: JAD210011. doi: 10.3233/JAD-210011.
PMID: 33967047